Kane Biotech Inc. (KNBIF)

Market Cap	5.96M
Revenue (ttm)	1.36M
Net Income (ttm)	-2.44M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Average Volume	393
Open	0.0328
Previous Close	0.0328
Day's Range	0.0328 - 0.0328
52-Week Range	0.0237 - 0.0978
Beta	0.16
RSI	72.70
Earnings Date	Nov 28, 2025

About Kane Biotech

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, a biofilm destabilizing formula with continuous activity; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine (PNAG) for treating wounds and otic infections. Its wound care product portfolio inclu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: KNBIF

Financial Performance

Financial numbers in CAD